Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for JAZZ

Stock Name	Jazz Pharmaceuticals PLC
Ticker	JAZZ(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	IE00B4Q5ZN47

Show aggregate JAZZ holdings

News associated with JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $185.00: Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target hoisted by The Goldman Sachs Group from $162.00 to $185.00 in a research report report published on Friday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently commented on […] - 2025-09-01 02:59:05
Implied FSMD Analyst Target Price: $49: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:25:46
Brokerages Set Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Target Price at $181.43: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target […] - 2025-08-19 03:06:58
Swiss National Bank Trims Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Swiss National Bank decreased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.6% in the first quarter, Holdings Channel reports. The firm owned 111,300 shares of the specialty pharmaceutical company’s stock after selling 4,100 shares during the period. Swiss National Bank’s holdings in Jazz Pharmaceuticals were worth $13,818,000 at the end of […] - 2025-08-15 05:24:55
Vanguard Group Inc. Has $747.06 Million Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vanguard Group Inc. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 0.3% in the first quarter, Holdings Channel reports. The institutional investor owned 6,017,403 shares of the specialty pharmaceutical company’s stock after selling 18,780 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Jazz Pharmaceuticals worth $747,061,000 at the […] - 2025-08-13 06:14:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Purchased by PNC Financial Services Group Inc.: PNC Financial Services Group Inc. lifted its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 5,128 shares of the specialty pharmaceutical company’s stock after acquiring an additional 379 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Jazz Pharmaceuticals were worth […] - 2025-08-13 04:38:53
Cetera Investment Advisers Purchases 444 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cetera Investment Advisers increased its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 4.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,536 shares of the specialty pharmaceutical company’s stock after purchasing an additional 444 shares during the quarter. Cetera Investment […] - 2025-08-11 04:18:46
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Allianz Asset Management GmbH: Allianz Asset Management GmbH lessened its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 24.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 58,745 shares of the specialty pharmaceutical company’s stock after selling 19,447 shares during the quarter. […] - 2025-07-28 04:36:57
Y Intercept Hong Kong Ltd Grows Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Y Intercept Hong Kong Ltd increased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 269.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 9,721 shares of the specialty pharmaceutical company’s stock after acquiring an additional 7,090 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Jazz Pharmaceuticals […] - 2025-07-25 06:11:00
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives $181.71 Consensus Price Target from Analysts: Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average […] - 2025-07-25 04:35:13
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by Xponance Inc.: Xponance Inc. raised its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 8.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,594 shares of the specialty pharmaceutical company’s stock after acquiring an additional 648 shares during the […] - 2025-07-17 07:42:48
Jazz Pharmaceuticals (NASDAQ:JAZZ) Now Covered by Deutsche Bank Aktiengesellschaft: Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $152.00 price target on the specialty pharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential […] - 2025-07-17 06:19:01
Cerity Partners LLC Acquires 4,744 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Cerity Partners LLC raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 14.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 37,949 shares of the specialty pharmaceutical company’s stock after acquiring an additional 4,744 shares during the quarter. Cerity Partners LLC’s holdings in Jazz Pharmaceuticals were worth $4,711,000 at […] - 2025-07-17 05:00:57
State of Michigan Retirement System Has $1.80 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): State of Michigan Retirement System increased its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,504 shares of the specialty pharmaceutical company’s stock after buying an additional 200 shares […] - 2025-07-15 06:28:18
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Acquired by OneDigital Investment Advisors LLC: OneDigital Investment Advisors LLC grew its stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,932 shares of the specialty pharmaceutical company’s stock after buying an additional 377 shares during […] - 2025-07-11 07:30:53
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Teacher Retirement System of Texas: Teacher Retirement System of Texas reduced its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 10.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,470 shares of the specialty pharmaceutical company’s stock after selling 1,902 shares during the quarter. Teacher Retirement System […] - 2025-07-11 05:14:57
Vontobel Holding Ltd. Lowers Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Vontobel Holding Ltd. trimmed its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 15.5% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 3,577 shares of the specialty pharmaceutical company’s stock after selling 656 shares during the period. Vontobel Holding Ltd.’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 05:30:53
Allspring Global Investments Holdings LLC Sells 489 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Allspring Global Investments Holdings LLC trimmed its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 3.1% during the first quarter, Holdings Channel.com reports. The fund owned 15,129 shares of the specialty pharmaceutical company’s stock after selling 489 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Jazz Pharmaceuticals were […] - 2025-07-08 04:32:49
Envestnet Portfolio Solutions Inc. Buys 1,223 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ): Envestnet Portfolio Solutions Inc. raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Free Report) by 38.9% during the 1st quarter, HoldingsChannel.com reports. The fund owned 4,369 shares of the specialty pharmaceutical company’s stock after buying an additional 1,223 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Jazz Pharmaceuticals were worth $542,000 at […] - 2025-06-27 05:08:51
15,296 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Ritholtz Wealth Management: Ritholtz Wealth Management bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,296 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,899,000. A number of other […] - 2025-06-17 07:00:52
Yousif Capital Management LLC Decreases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Yousif Capital Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 12,644 shares of the specialty pharmaceutical company’s stock after selling 342 shares during the quarter. Yousif Capital Management LLC’s holdings in Jazz Pharmaceuticals were worth $1,570,000 as of […] - 2025-06-17 05:08:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 22.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,102 shares of the specialty pharmaceutical company’s stock after purchasing an additional 743 shares during […] - 2025-06-13 04:34:51
2,265 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Merit Financial Group LLC: Merit Financial Group LLC bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 2,265 shares of the specialty pharmaceutical company’s stock, valued at approximately $281,000. Several other large investors have also recently modified their holdings of JAZZ. IFP Advisors Inc bought […] - 2025-06-12 05:32:55
Wedmont Private Capital Sells 903 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Wedmont Private Capital trimmed its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 13.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,912 shares of the specialty pharmaceutical company’s stock after selling 903 shares during the period. […] - 2025-06-10 05:33:02
Focus Partners Wealth Invests $551,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […] - 2025-05-20 07:12:52
How The Pieces Add Up: IJH Headed For $69: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:47
Hsbc Holdings PLC Acquires 605 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ): Hsbc Holdings PLC boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the specialty pharmaceutical company’s stock after buying an additional 605 […] - 2025-05-09 05:34:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Townsquare Capital LLC: Townsquare Capital LLC lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 79.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,540 shares of the specialty pharmaceutical company’s stock after buying an additional 1,568 shares during the quarter. Townsquare […] - 2025-04-21 05:00:54
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal Can: Bank of Montreal Can reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,194 shares of the specialty pharmaceutical company’s stock after selling 2,253 shares during the period. Bank of […] - 2025-04-17 05:42:52
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MN: Wells Fargo & Company MN lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 96,952 shares of the specialty pharmaceutical company’s stock after selling 20,063 shares during the period. Wells Fargo & Company MN’s holdings in Jazz Pharmaceuticals were worth […] - 2025-04-16 05:27:14

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) JAZZ holdings

Date	Number of JAZZ Shares Held	Base Market Value of JAZZ Shares	Local Market Value of JAZZ Shares	Change in JAZZ Shares Held	Change in JAZZ Base Value	Current Price per JAZZ Share Held	Previous Price per JAZZ Share Held
2025-12-03 (Wednesday)	42,455	USD 7,094,231	USD 7,094,231	0	USD 16,558	USD 167.1	USD 166.71
2025-12-02 (Tuesday)	42,455	USD 7,077,673	USD 7,077,673	1,515	USD 31,080	USD 166.71	USD 172.12
2025-12-01 (Monday)	40,940	USD 7,046,593	USD 7,046,593	0	USD -180,545	USD 172.12	USD 176.53
2025-11-28 (Friday)	40,940	USD 7,227,138	USD 7,227,138	101	USD 1,902	USD 176.53	USD 176.92
2025-11-27 (Thursday)	40,839	USD 7,225,236	USD 7,225,236	0	USD 0	USD 176.92	USD 176.92
2025-11-26 (Wednesday)	40,839	USD 7,225,236	USD 7,225,236	303	USD -73,271	USD 176.92	USD 180.05
2025-11-25 (Tuesday)	40,536	USD 7,298,507	USD 7,298,507	505	USD 56,899	USD 180.05	USD 180.9
2025-11-24 (Monday)	40,031	USD 7,241,608	USD 7,241,608	101	USD 176,793	USD 180.9	USD 176.93
2025-11-21 (Friday)	39,930	USD 7,064,815	USD 7,064,815	0	USD 47,517	USD 176.93	USD 175.74
2025-11-20 (Thursday)	39,930	USD 7,017,298	USD 7,017,298	-404	USD -84,713	USD 175.74	USD 176.08
2025-11-19 (Wednesday)	40,334	USD 7,102,011	USD 7,102,011	101	USD -160,850	USD 176.08	USD 180.52
2025-11-18 (Tuesday)	40,233	USD 7,262,861	USD 7,262,861	808	USD 557,063	USD 180.52	USD 170.09
2025-11-17 (Monday)	39,425	USD 6,705,798	USD 6,705,798	0	USD 1,144,113	USD 170.09	USD 141.07

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of JAZZ by Blackrock for IE00BDZVHG35

Show aggregate share trades of JAZZ

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,515 173.600 166.540 167.246 USD 253,378 124.18
2025-11-28 BUY 101 177.660 175.060 175.320 USD 17,707 123.68
2025-11-26 BUY 303 181.610 176.660 177.155 USD 53,678 123.14
2025-11-26 BUY 303 181.610 176.660 177.155 USD 53,678 123.14
2025-11-25 BUY 505 182.750 178.010 178.484 USD 90,134 122.85
2025-11-24 BUY 101 182.270 172.190 173.198 USD 17,493 122.56
2025-11-20 SELL -404 179.005 174.475 174.928 USD -70,671 122.00 Loss of -21,381 on sale
2025-11-19 BUY 101 180.400 174.760 175.324 USD 17,708 121.72
2025-11-18 BUY 808 182.990 169.870 171.182 USD 138,315 121.42
2025-11-14 BUY 101 142.810 139.265 139.619 USD 14,102 121.06
2025-11-12 BUY 101 140.680 136.270 136.711 USD 13,808 120.86
2025-11-10 BUY 100 134.635 132.170 132.416 USD 13,242 120.71
2025-11-06 BUY 100 144.970 130.792 132.209 USD 13,221 120.58
2025-11-04 BUY 101 139.065 136.000 136.307 USD 13,767 120.40
2025-10-30 BUY 505 138.790 134.000 134.479 USD 67,912 120.11
2025-10-29 BUY 202 135.730 137.580 137.395 USD 27,754 120.02
2025-10-22 SELL -404 138.520 139.750 139.627 USD -56,409 119.49 Loss of -8,136 on sale
2025-10-20 BUY 202 134.850 137.390 137.136 USD 27,701 119.29
2025-10-17 BUY 504 136.060 136.610 136.555 USD 68,824 119.19
2025-10-15 BUY 800 135.800 136.510 136.439 USD 109,151 119.10
2025-10-03 BUY 700 139.480 140.390 140.299 USD 98,209 118.88
2025-10-02 BUY 100 137.210 138.150 138.056 USD 13,806 118.77
2025-09-30 BUY 200 131.800 131.930 131.917 USD 26,383 118.58
2025-09-26 BUY 200 127.000 129.520 129.268 USD 25,854 118.47
2025-09-25 BUY 200 127.800 129.250 129.105 USD 25,821 118.41
2025-09-18 BUY 106 131.190 131.620 131.577 USD 13,947 118.33
2025-09-17 BUY 318 129.540 130.870 130.737 USD 41,574 118.26
2025-07-17 SELL -212 114.860 116.770 116.579 USD -24,715 118.30 Profit of 365 on sale
2025-07-16 BUY 385 116.080 116.230 116.215 USD 44,743 118.31
2025-07-11 SELL -840 110.270 111.970 111.800 USD -93,912 118.45 Profit of 5,588 on sale
2025-07-02 BUY 5,775 109.920 110.690 110.613 USD 638,790 118.66
2025-06-25 BUY 210 107.120 108.310 108.191 USD 22,720 118.99
2025-06-20 BUY 1,341 107.510 108.790 108.662 USD 145,716 119.23
2025-06-11 BUY 202 110.500 113.590 113.281 USD 22,883 119.78
2025-06-10 BUY 202 113.000 114.300 114.170 USD 23,062 119.83
2025-06-04 SELL -101 109.450 112.290 112.006 USD -11,313 120.13 Profit of 820 on sale
2025-04-23 BUY 101 104.190 106.770 106.512 USD 10,758 123.56
2025-04-10 SELL -808 102.050 108.080 107.477 USD -86,841 125.74 Profit of 14,758 on sale
2025-04-08 SELL -101 102.820 113.540 112.468 USD -11,359 126.19 Profit of 1,385 on sale
2025-04-07 SELL -101 106.930 111.650 111.178 USD -11,229 126.41 Profit of 1,538 on sale
2025-04-04 SELL -505 110.040 117.120 116.412 USD -58,788 126.60 Profit of 5,146 on sale
2025-04-01 BUY 875 124.990 127.400 127.159 USD 111,264 126.62
2025-03-31 SELL -297 124.150 124.680 124.627 USD -37,014 126.65 Profit of 602 on sale
2025-03-21 BUY 1,424 138.760 140.030 139.903 USD 199,222 126.18
2025-03-14 SELL -1,504 137.960 138.200 138.176 USD -207,817 125.20 Loss of -19,520 on sale
2025-03-07 SELL -188 138.810 141.360 141.105 USD -26,528 124.33 Loss of -3,154 on sale
2025-03-04 SELL -94 138.950 141.280 141.047 USD -13,258 123.65 Loss of -1,635 on sale
2025-02-25 BUY 188 139.670 140.520 140.435 USD 26,402 122.06
2025-02-19 SELL -94 134.960 137.180 136.958 USD -12,874 121.02 Loss of -1,499 on sale
2025-02-13 BUY 282 136.820 138.270 138.125 USD 38,951 119.90
2025-02-12 BUY 94 135.440 136.550 136.439 USD 12,825 119.58
2025-02-11 BUY 376 129.980 131.500 131.348 USD 49,387 119.36
2024-12-30 SELL -4,047 122.970 124.600 124.437 USD -503,597 117.80 Loss of -26,850 on sale
2024-11-18 SELL -1,590 117.590 122.880 122.351 USD -194,538 113.42 Loss of -14,201 on sale
2024-11-08 SELL -106 123.610 123.970 123.934 USD -13,137 111.67 Loss of -1,300 on sale
2024-10-21 SELL -106 113.120 115.480 115.244 USD -12,216 0.00 Loss of -12,216 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,515	173.600	166.540	167.246	USD 253,378	124.18
2025-11-28	BUY	101	177.660	175.060	175.320	USD 17,707	123.68
2025-11-26	BUY	303	181.610	176.660	177.155	USD 53,678	123.14
2025-11-26	BUY	303	181.610	176.660	177.155	USD 53,678	123.14
2025-11-25	BUY	505	182.750	178.010	178.484	USD 90,134	122.85
2025-11-24	BUY	101	182.270	172.190	173.198	USD 17,493	122.56
2025-11-20	SELL	-404	179.005	174.475	174.928	USD -70,671	122.00 Loss of -21,381 on sale
2025-11-19	BUY	101	180.400	174.760	175.324	USD 17,708	121.72
2025-11-18	BUY	808	182.990	169.870	171.182	USD 138,315	121.42
2025-11-14	BUY	101	142.810	139.265	139.619	USD 14,102	121.06
2025-11-12	BUY	101	140.680	136.270	136.711	USD 13,808	120.86
2025-11-10	BUY	100	134.635	132.170	132.416	USD 13,242	120.71
2025-11-06	BUY	100	144.970	130.792	132.209	USD 13,221	120.58
2025-11-04	BUY	101	139.065	136.000	136.307	USD 13,767	120.40
2025-10-30	BUY	505	138.790	134.000	134.479	USD 67,912	120.11
2025-10-29	BUY	202	135.730	137.580	137.395	USD 27,754	120.02
2025-10-22	SELL	-404	138.520	139.750	139.627	USD -56,409	119.49 Loss of -8,136 on sale
2025-10-20	BUY	202	134.850	137.390	137.136	USD 27,701	119.29
2025-10-17	BUY	504	136.060	136.610	136.555	USD 68,824	119.19
2025-10-15	BUY	800	135.800	136.510	136.439	USD 109,151	119.10
2025-10-03	BUY	700	139.480	140.390	140.299	USD 98,209	118.88
2025-10-02	BUY	100	137.210	138.150	138.056	USD 13,806	118.77
2025-09-30	BUY	200	131.800	131.930	131.917	USD 26,383	118.58
2025-09-26	BUY	200	127.000	129.520	129.268	USD 25,854	118.47
2025-09-25	BUY	200	127.800	129.250	129.105	USD 25,821	118.41
2025-09-18	BUY	106	131.190	131.620	131.577	USD 13,947	118.33
2025-09-17	BUY	318	129.540	130.870	130.737	USD 41,574	118.26
2025-07-17	SELL	-212	114.860	116.770	116.579	USD -24,715	118.30 Profit of 365 on sale
2025-07-16	BUY	385	116.080	116.230	116.215	USD 44,743	118.31
2025-07-11	SELL	-840	110.270	111.970	111.800	USD -93,912	118.45 Profit of 5,588 on sale
2025-07-02	BUY	5,775	109.920	110.690	110.613	USD 638,790	118.66
2025-06-25	BUY	210	107.120	108.310	108.191	USD 22,720	118.99
2025-06-20	BUY	1,341	107.510	108.790	108.662	USD 145,716	119.23
2025-06-11	BUY	202	110.500	113.590	113.281	USD 22,883	119.78
2025-06-10	BUY	202	113.000	114.300	114.170	USD 23,062	119.83
2025-06-04	SELL	-101	109.450	112.290	112.006	USD -11,313	120.13 Profit of 820 on sale
2025-04-23	BUY	101	104.190	106.770	106.512	USD 10,758	123.56
2025-04-10	SELL	-808	102.050	108.080	107.477	USD -86,841	125.74 Profit of 14,758 on sale
2025-04-08	SELL	-101	102.820	113.540	112.468	USD -11,359	126.19 Profit of 1,385 on sale
2025-04-07	SELL	-101	106.930	111.650	111.178	USD -11,229	126.41 Profit of 1,538 on sale
2025-04-04	SELL	-505	110.040	117.120	116.412	USD -58,788	126.60 Profit of 5,146 on sale
2025-04-01	BUY	875	124.990	127.400	127.159	USD 111,264	126.62
2025-03-31	SELL	-297	124.150	124.680	124.627	USD -37,014	126.65 Profit of 602 on sale
2025-03-21	BUY	1,424	138.760	140.030	139.903	USD 199,222	126.18
2025-03-14	SELL	-1,504	137.960	138.200	138.176	USD -207,817	125.20 Loss of -19,520 on sale
2025-03-07	SELL	-188	138.810	141.360	141.105	USD -26,528	124.33 Loss of -3,154 on sale
2025-03-04	SELL	-94	138.950	141.280	141.047	USD -13,258	123.65 Loss of -1,635 on sale
2025-02-25	BUY	188	139.670	140.520	140.435	USD 26,402	122.06
2025-02-19	SELL	-94	134.960	137.180	136.958	USD -12,874	121.02 Loss of -1,499 on sale
2025-02-13	BUY	282	136.820	138.270	138.125	USD 38,951	119.90
2025-02-12	BUY	94	135.440	136.550	136.439	USD 12,825	119.58
2025-02-11	BUY	376	129.980	131.500	131.348	USD 49,387	119.36
2024-12-30	SELL	-4,047	122.970	124.600	124.437	USD -503,597	117.80 Loss of -26,850 on sale
2024-11-18	SELL	-1,590	117.590	122.880	122.351	USD -194,538	113.42 Loss of -14,201 on sale
2024-11-08	SELL	-106	123.610	123.970	123.934	USD -13,137	111.67 Loss of -1,300 on sale
2024-10-21	SELL	-106	113.120	115.480	115.244	USD -12,216	0.00 Loss of -12,216 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of JAZZ

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	112,073	0	208,473	53.8%
2025-09-18	174,563	0	259,899	67.2%
2025-09-17	181,867	0	321,522	56.6%
2025-09-16	144,278	295	264,733	54.5%
2025-09-15	104,621	10	235,855	44.4%
2025-09-12	204,437	0	280,698	72.8%
2025-09-11	110,769	58	388,046	28.5%
2025-09-10	95,550	0	204,768	46.7%
2025-09-09	105,946	5	218,517	48.5%
2025-09-08	114,184	73	205,785	55.5%
2025-09-05	176,466	9	300,437	58.7%
2025-09-04	217,876	0	386,092	56.4%
2025-09-03	159,099	0	265,396	59.9%
2025-09-02	245,766	1,378	345,991	71.0%
2025-08-29	188,379	0	252,582	74.6%
2025-08-28	166,386	2,760	218,636	76.1%
2025-08-27	141,870	22,558	195,620	72.5%
2025-08-26	217,585	11,530	291,596	74.6%
2025-08-25	225,170	0	314,430	71.6%
2025-08-22	135,885	193	263,628	51.5%
2025-08-21	107,180	329	288,390	37.2%
2025-08-20	145,789	0	282,575	51.6%
2025-08-19	211,546	0	381,132	55.5%
2025-08-18	136,130	58	223,196	61.0%
2025-08-15	114,778	0	190,467	60.3%
2025-08-14	125,124	0	224,730	55.7%
2025-08-13	265,703	15,414	607,343	43.7%
2025-08-12	124,715	15	276,805	45.1%
2025-08-11	149,930	0	300,250	49.9%
2025-08-08	152,810	4,111	258,684	59.1%
2025-08-07	456,871	104	781,305	58.5%
2025-08-06	788,262	31	1,198,162	65.8%
2025-08-05	177,955	42	421,699	42.2%
2025-08-04	124,630	10	224,655	55.5%
2025-08-01	144,039	4	220,460	65.3%
2025-07-31	81,903	75	163,020	50.2%
2025-07-30	70,567	18	141,254	50.0%
2025-07-29	95,304	13	189,722	50.2%
2025-07-28	86,232	41	165,168	52.2%
2025-07-25	100,335	0	159,541	62.9%
2025-07-24	104,031	10	197,575	52.7%
2025-07-23	89,333	413	211,213	42.3%
2025-07-22	245,642	4,000	510,584	48.1%
2025-07-21	115,065	22	156,579	73.5%
2025-07-18	143,324	0	210,983	67.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE